ArticleBMC cancer2024

Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progression.

Peng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.